Healthcare

Biosensors clarifies reported FDA product ban

It was caused by administrative errors.

Are expensive healthcare stocks still worth it?

Prices are feared to dip in coming months.

Singapore should stop fretting over medical tourism woes, say analysts

Regional competitors are no match for local healthcare providers.

Would RafflesMed’s expansion plan prove counterproductive?

They’re currently bombarded by expenses from all fronts.

Private healthcare providers to struggle with local expansion, say analysts

Developing countries offer attractive alternatives, though.

Q&M Dental transfers over 300,000 shares to NUS

It's a charitable gift to the Faculty of Dentistry.